Whitepaper: Addressing Cell and Gene Therapy Manufacturing Challenges with Digital Solutions

The increasing demand for CGT requires scaling of production pipelines. Digital solutions are needed to support commercial production. In our whitepaper, we analyze the impact of Pharma 4.0 on CGT manufacturing and look at different options such as cloud-based and software-as-a-service offerings.
Thumbnail-Adressing CGT
Back to top